Literature DB >> 31464561

CVD risk factors and surrogate markers - Urban-rural differences.

Joel Nuotio1,2, Lauri Vähämurto1, Katja Pahkala1,3, Costan G Magnussen1,4, Nina Hutri-Kähönen5, Mika Kähönen6, Tomi Laitinen7, Leena Taittonen8, Päivi Tossavainen9, Terho Lehtimäki10, Eero Jokinen11, Jorma S A Viikari12, Olli Raitakari13, Markus Juonala1,12,14.   

Abstract

Aims: Disparity in cardiovascular disease (CVD) mortality and risk factor levels between urban and rural regions has been confirmed worldwide. The aim of this study was to examine how living in different community types (urban-rural) in childhood and adulthood are related to cardiovascular risk factors and surrogate markers of CVD such as carotid intima-media thickness (IMT) and left ventricular mass (LVM).
Methods: The study population comprised 2903 participants (54.1% female, mean age 10.5 years in 1980) of the Cardiovascular Risk in Young Finns Study who had been clinically examined in 1980 (age 3-18 years) and had participated in at least one adult follow-up (2001-2011).
Results: In adulthood, urban residents had lower systolic blood pressure (-1 mmHg), LDL-cholesterol (-0.05 mmol/l), lower body mass index (-1.0 kg/m2) and glycosylated haemoglobin levels (-0.05 mmol/mol), and lower prevalence of metabolic syndrome (19.9 v. 23.7%) than their rural counterparts. In addition, participants continuously living in urban areas had significantly lower IMT (-0.01 mm), LVM (1.59 g/m2.7) and pulse wave velocity (-0.22 m/s) and higher carotid artery compliance (0.07%/10 mmHg) compared to persistently rural residents. The differences in surrogate markers of CVD were only partially attenuated when adjusted for cardiovascular risk factors. Conclusions: Participants living in urban communities had a more favourable cardiovascular risk factor profile than rural residents. Furthermore, participants continuously living in urban areas had less subclinical markers related to CVD compared with participants living in rural areas. Urban-rural differences in cardiovascular health might provide important opportunities for optimizing prevention by targeting areas of highest need.

Entities:  

Keywords:  Atherosclerosis; arterial stiffness; left ventricular mass; risk factors; rural; urban

Mesh:

Substances:

Year:  2019        PMID: 31464561     DOI: 10.1177/1403494819869816

Source DB:  PubMed          Journal:  Scand J Public Health        ISSN: 1403-4948            Impact factor:   3.021


  4 in total

Review 1.  Does Connected Health Technology Improve Health-Related Outcomes in Rural Cardiac Populations? Systematic Review Narrative Synthesis.

Authors:  Matthew James Fraser; Trish Gorely; Chris O'Malley; David J Muggeridge; Oonagh M Giggins; Daniel R Crabtree
Journal:  Int J Environ Res Public Health       Date:  2022-02-17       Impact factor: 3.390

2.  The Relationship Between the Metabolic Syndrome and the Place of Residence in the Local Community on the Example of the Janów Lubelski District in Eastern Poland: A Population-Based Study.

Authors:  Grzegorz Józef Nowicki; Barbara Ślusarska; Katarzyna Naylor; Andrzej Prystupa; Ewa Rudnicka-Drożak; Ulyana Halyuk; Petro Pokotylo
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-06       Impact factor: 3.168

3.  Identification of cardiovascular risk factors among urban and rural Malaysian youths.

Authors:  Noor Shafina Mohd Nor; Yung-An Chua; Suraya Abdul Razak; Zaliha Ismail; Hapizah Nawawi
Journal:  BMC Cardiovasc Disord       Date:  2022-02-23       Impact factor: 2.298

4.  The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study.

Authors:  Krzysztof Studziński; Tomasz Tomasik; Adam Windak; Maciej Banach; Ewa Wójtowicz; Mirosław Mastej; Maciej Tomaszewski; Dimitri P Mikhailidis; Peter P Toth; Alberico Catapano; Kausik K Ray; George Howard; Gregory Y H Lip; Fadi J Charchar; Naveed Sattar; Bryan Williams; Thomas M MacDonald; Peter E Penson; Jacek J Jóźwiak
Journal:  J Clin Med       Date:  2021-11-30       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.